Patents by Inventor Leon H. Parker, IV

Leon H. Parker, IV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for modulating vascular development
    Patent number: 8790646
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: July 29, 2014
    Assignee: Genentech Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon H. Parker, IV, Jo-Anne S. Hongo, Maike Schmidt
  • TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION
    Publication number: 20140005113
    Abstract: The present invention provides methods of using RASIP1 agonists and antagonists to modulate vascular barrier function and regulate new vessel formation, and to treat related disorders.
    Type: Application
    Filed: September 10, 2013
    Publication date: January 2, 2014
    Applicant: Genentech, Inc.
    Inventors: Weilan Ye, Leon H. Parker, IV, Christopher W. Wilson
  • COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
    Publication number: 20120003208
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Application
    Filed: October 14, 2010
    Publication date: January 5, 2012
    Applicant: Genentech, Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon H. Parker, IV, Jo-Anne S. Hongo, Maike Schmidt
  • COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
    Publication number: 20090297512
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Application
    Filed: January 22, 2009
    Publication date: December 3, 2009
    Applicant: Genentech, Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon H. Parker, IV, Jo-Anne S. Hongo, Maike Schmidt